Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Label Opened Inhalers with Required Dates

Franklin, New Hampshire Survey Completed on 06-20-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that medications, specifically inhalers, were not labeled with open or expiration dates on two of three medication carts inspected. During the inspection, multiple opened inhalers belonging to several residents were found without the required labeling, including Incruse Ellipta, Breztri, Spiriva, and Trelegy inhalers. Licensed Practical Nurses present at the time confirmed that these inhalers were opened and not labeled as per manufacturer instructions. A review of the manufacturer's instructions for each inhaler indicated that labeling with the date opened and discard date is required to ensure proper use and disposal. The facility's own policy also mandates that medications and biologicals be stored according to manufacturer or pharmacy recommendations to maintain their integrity and support safe administration. The failure to label these medications as required constitutes a deficiency in following professional standards for medication storage and labeling.

An unhandled error has occurred. Reload 🗙